🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

BPA2023 | FOURTH SYMPOSIUM ANNOUNCEMENT The Markers in Neuropsychiatric Disorders (MiND) study themindstudy Presented by Dr Christa Dang, Dhamidhu Eratne, Wei-Hsuan Michelle Chiu, @MattJYKang. Chaired by Prof Dennis Velakoulis, with discussion led by Dr Courtney Lewis

ONLY 2 MONTHS until Translation in the Tropics BPA 2023!!!! Don't forget to register: biolpsychaustralia.com.au/annual-confere…

An eloquent and important statement from Menzies Research supporting the Uluru Statement from the Heart. AAMRI stands with Menzies in support of an Indigenous Voice to parliament and having this formally recognised in our Constitution.

Preclinical NeuropPsychiatry Laboratory NeuRA (Neuroscience Research Australia) presenting fundamental research @PsychosisAus #APC2023, and learning valuable lessons about lived experience, treatment, advocacy and policy.

Launched today: AAMRI’s Sex and Gender Policy Recommendations for Health & Medical Research. “Entrenching this thinking will create better research, better researchers and ultimately the best outcomes for patients.” - Dr Saraid Billiards, AAMRI CEO. More: aamri.org.au/news-events/aa…

If a grant includes a rat model of dopamine dysregulation and postmortem brains from people with schizophrenia. How does one combat review comments like "this is a study on...rather than a study to understand anything about schizophrenia" (3 other favourable reviews) #NH&MRC

AUBREY LEWIS AWARD | APPLICATIONS OPEN NOW Open to BPA members < 10 years post-PhD with an outstanding track record in biological psychiatry research Deadline: Friday 1 March 2024 More information: biolpsychaustralia.com.au/annual-confere… #BPA2024

Congrats Sophie Debs! The first paper from a large preclinical study looking at sex differences in behaviour and gene expression in multiple brain regions after raloxifene treatment in the rat maternal immune activation model of dopamine dysregulation. doi.org/10.1016/j.bbi.…

BPA this year is shaping up to be awesome! Who’s coming!? Prof. Chris Langmead A/Prof Jess Nithianantharajah 🧠👩🏾‍🔬 🇱🇰🇦🇺 Anthony Hannan Rachel Hill Dr. Tertia Purves-Tyson

📣BPA ECRN Webinar - Science Communication📣 Please join us for our first webinar of the year on Science Communication, and hear from our outstanding line-up of guest speakers, @Tillsify, jr 🩻 and A/Prof Jen Martin @scidocmartin.bsky.social🗣️ Register and read speaker bios here👇 events.humanitix.com/bpa-ecrn-webin…

ISAAC SCHWEITZER LECTURE | BPA 2024 BPA has the great pleasure to announce that Professor Colleen Loo will present the 2024 Isaac Schweitzer Lecture at #BPA2024 Don't forget: symposia submission deadline is May 24, 5pm AEST! BPA 2024 | 4-5 November 2024 | Sydney, NSW

Please RT! Australasian Neuroscience Society Indigenous travel award closes in 1 week! Open to Aboriginal, Torres Strait Islander and Māori researchers. Check out the EOI for more details Australasian Neuroscience Society (ANS) ALBA Network forms.office.com/pages/response…

So proud of Sophie Debs , another study contributing to her almost complete PhD thesis published, showing potentially altered stress signalling in the midbrain in schizophrenia doi.org/10.1016/j.jpsy…

BPA2024 is shaping up to be another great meeting of basic and clinical researchers in biological psychiatry from across Australia

Preclinical Neuropsychiatry Laboratory and associates NeuRA (Neuroscience Research Australia) celebrating Sophie Debs PhD submission - CONGRATS. Lucky to have all these people associated with my team!

Excited to share that registrations are open (and free!) for Addiction Neuroscience Australia second annual symposium, Sunday Nov 3rd. See you there!

Collaboration & collegiality is key to good research! Expertise from Kristie Smith and Steve Kassem at NeuRA (Neuroscience Research Australia) and Teri Furlong from SBMS UNSW. Honours student Iveta Gavljak with microglia staining of brains from a preclinical study lead by Sophie Debs.

#WorldMentalHealthDay: A new type of antipsychotic medication for #schizophrenia has been approved in the US. For #worldmentalhealthday, NeuRA’s Dr. Tertia Purves-Tyson shares how #Cobenfy works and what makes it different to existing treatments: neura.edu.au/news-media/res…

✨SAVE THE DATE!✨ 26-28 OCTOBER 2025 | MELBOURNE Further details coming soon .... #BPA2025

excitement is mounting for BPA2025! Symposium submissions are open until May 15th.